Mycophenolate Mofetil — Class III drug recall D-1047-2016
Terminated recall by Attix Pharmaceuticals Inc, reported 2016-06-29, distributed in CO. cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
| Recall number | D-1047-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Attix Pharmaceuticals Inc, Toronto, N/A, Canada |
| Recall initiated | 2016-05-18 |
| Classified | 2016-06-21 |
| Reported by FDA | 2016-06-29 |
| Terminated | 2016-07-26 |
| Distributed | CO |
| Reason classes | cgmp |
| Lot numbers | 151201, A3160A |
| Expiration dates | 2017-11-20 |
Product
Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada
Reason for recall
cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1047-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.